Armstrong Fleming & Moore’s Pfizer PFE Stock Holding History

Armstrong Fleming & Moore’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$277K	Buy	9,868 +70	+0.7%	+$1.86K	0.12%	87
2025 Q4	$244K	Sell	9,798 -57	-0.6%	-$1.44K	0.11%	89
2025 Q3	$251K	Hold	9,855	–	–	0.12%	91
2025 Q2	$239K	Buy	+9,855	New	+$230K	0.13%	90
2025 Q1	–	Sell	-11,802	Closed	-$313K	–	137
2024 Q4	$313K	Sell	11,802 -707	-6%	-$19.2K	0.19%	76
2024 Q3	$362K	Buy	12,509 +500	+4%	+$14.6K	0.21%	69
2024 Q2	$336K	Sell	12,009 -126	-1%	-$3.47K	0.22%	68
2024 Q1	$337K	Hold	12,135	–	–	0.23%	73
2023 Q4	$349K	Hold	12,135	–	–	0.26%	68
2023 Q3	$403K	Hold	12,135	–	–	0.39%	57
2023 Q2	$445K	Buy	+12,135	New	+$472K	0.41%	54

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Armstrong Fleming & Moore's PFE Position: Q1 2026 in Review

Armstrong Fleming & Moore increased its Pfizer (PFE) stake by 0.71% in Q1 2026, buying an estimated $1.86K and bringing the position to 9,868 shares worth $277K. The position accounts for 0.12% of the portfolio, ranked #87.

Armstrong Fleming & Moore first reported a position in PFE in Q2 2023 and has held it in 11 quarters since. The position peaked at $445K in Q2 2023. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

Armstrong Fleming & Moore held 9,868 shares of Pfizer worth $277K as of Q1 2026.
Armstrong Fleming & Moore bought 70 Pfizer shares in Q1 2026, an estimated $1.86K.
Pfizer made up 0.12% of Armstrong Fleming & Moore's portfolio in Q1 2026, its #87 holding.
Armstrong Fleming & Moore first reported a position in Pfizer in Q2 2023 and has held it in 11 quarters since.
Armstrong Fleming & Moore's Pfizer position peaked at $445K in Q2 2023.
2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Armstrong Fleming & Moore's 13F filing for Q1 2026, filed 13 Apr 2026.